CUE Cue Biopharma
Company Analysis
Latest News
🔴 Cue Biopharma is trading 5.53% down today following its 1-for-30 reverse stock split on July 23rd
Cue Biopharma is trading 5.53% down today at $31.26 as the stock pulls back. • The decline follows a 1-for-30 reverse stock split that took effect on July 23,...
🔴 Cue Biopharma is trading 5% down today following a multi-day rally
Cue Biopharma is trading 5% down at $32.48 following a sharp multi-day rally, with no immediate news catalyst identified for the move. • The decline likely...
🟢 Cue Biopharma is trading 5% up today as shares extend volatile gains following recent financing and licensing deals
Cue Biopharma is trading at $32.51 (5% up) as shares extend a volatile move following recent financing and licensing news. • The stock previously spiked...
🔴 Cue Biopharma is trading 6.2% down today as profit-taking and dilution concerns follow its recent deal-fueled rally
Cue Biopharma is trading at $29.02 (6.2% down) as the stock extends a pullback following a volatile rally driven by a new licensing deal and financing...
🔴 Cue Biopharma is trading 5.5% down today in a pullback following its recent licensing deal rally
Cue Biopharma is trading 5.5% down at $29.45 today as the stock pulls back following a sharp rally driven by a new licensing deal and financing-related...
🟢 Cue Biopharma is trading 10.1% up
Cue Biopharma is trading at $30.60, up 10.1% from a comparison close of $27.79 during regular trading. This is a price-action follow-up, so a separate catalyst...
🟢 Cue Biopharma surges 6.2% as $7.5M milestone payment from Boehringer Ingelheim fuels rebound
Cue Biopharma shares are trading 6.2% higher today at $29.50, buoyed by a $7.5 million milestone payment** from Boehringer Ingelheim, which was reported on...
🔴 Cue Biopharma is trading 7% down today as $50M private placement sparks dilution concerns
Cue Biopharma is trading 7% down at $25.84, extending a sharp multi-day pullback following its $50 million private placement of common stock and pre-funded...
🔴 Cue Biopharma extends decline after $50M private placement announced last week
Cue Biopharma is trading at $25.50 (8.2% down) in pre-market, extending a sharp pullback this week. The ongoing decline follows the company's announcement...
🔴 Cue Biopharma is trading 6% down today on profit-taking after recent financing rally
Cue Biopharma is trading 6% down at $26.77 as the stock undergoes consolidation following a sharp multi-day rally driven by positive partnership and financing...
🔴 Cue Biopharma is trading 5.2% down today following its reverse split and private placement
Cue Biopharma is trading at $29.32 (5.2% down) as investors digest recent capital structure changes, including a reverse stock split and a private...
🟢 Cue Biopharma is trading 6.4% up today following a reverse stock split and $50 million private placement
Cue Biopharma is trading 6.4% up at $32.90 in pre-market action as the market reacts to significant changes in the company's capital structure. • The company...
🔴 Cue Biopharma is trading 11.1% down
Cue Biopharma is trading at $32.71, down 11.1% from a comparison close of $36.78 during regular trading. This is a price-action follow-up, so a separate...
🔴 Cue Biopharma is trading 6.1% down today after pricing $50M private placement at a discount
Cue Biopharma is trading 6.1% down at $34.55 after pricing a $50 million private placement at a discount to its recent market value. • The offering is priced...
🔴 Cue Biopharma is trading 14% down today after $50M private placement pricing
Cue Biopharma is trading at $31.50 (14% down) after announcing a $50 million private placement of common stock and pre-funded warrants priced at approximately...
Cue Biopharma Announces $50 Million Private Placement Financing
Cue Biopharma, Inc. has entered into a securities purchase agreement with accredited investors for a private placement expected to generate gross proceeds of...
🟢 Cue Biopharma is trading 12.1% up today after announcing a $50M private placement
Cue Biopharma is trading 12.1% up at $40.92 after announcing a $50 million private placement priced at $33.21 per share with accredited investors. • The...
🟢 Cue Biopharma is trading 10.5% up
Cue Biopharma is trading at $40.34, up 10.5% from a comparison close of $36.51 during pre-market. This is a price-action follow-up, so a separate catalyst may...
Cue Biopharma Lands $50 Million From Big-Name Biotech Funds — But Can a Cash-Burning Micro-Cap Justify a 42% Weekly Rally?
Shares of Cue Biopharma surged 9.6% in pre-market trading to $40.01 after the clinical-stage drugmaker announced a $50 million private placement — its second...
🟢 Cue Biopharma is trading 9.6% up today after announcing a $50M private placement
Cue Biopharma is trading 9.6% up at $40.01 in pre-market after announcing a $50 million private placement of common stock and pre-funded warrants to...